Print Email

MASCC/ISOO Mucositis Guidelines

Publications Related to Latest Version of the Guidelines

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Cancer. 2014 May 15;120(10):1453-61. Review. Erratum in: Cancer. 2015 Apr 15;121(8):1339.  Free Article

The MASCC/ISOO Mucositis Guidelines: dissemination and clinical impact. Lalla RV, Ashbury FD.

Systematic review of basic oral care for the management of oral mucositis in cancer patients. McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, Elad S, Gibson F, Oberle-Edwards LK, Bowen J, Lalla RV.

Systematic Review of Anti-inflammatory Agents for the Management of Oral Mucositis in Cancer Patients. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias E, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV.

Systematic Review of Antimicrobials, Mucosal Coating Agents, Anesthetics, and Analgesics, for the Management of Oral Mucositis in Cancer Patients. Saunders D, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Dennis K, Bowen J, Lalla RV.

Systematic review of natural agents for the management of oral mucositis in cancer patients. Yarom N, Ariyawardana A, Hovan A, Barasch A, Jarvis V, Jensen SB, Zadik Y, Elad S, Bowen J, Lalla RV.

Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Jensen SB, Jarvis V, Zadik Y, Barasch A, Ariyawardana A, Hovan A, Yarom N, Lalla RV, Bowen J, Elad S.

Emerging Evidence on the Pathobiology of Mucositis. Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV.

Risk of Oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis. Elting LS, Chang YC, Parelkar P, Boers-Doets, CB, Michelet M, Hita G, Rouleau T, Cooksley C, Halm J, Vithala M, Bossi P, Escalante C, Brennan MT; On behalf of Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO).

The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles. Lalla RV.

Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update. Bowen, JM, Elad S, Hutchins RD, Lalla RV.

Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process. Elad S, Bowen JM, Zadik Y, Lalla RV.

Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Gibson RJ, Keefe DMK, Lalla RV, Bateman E, Bljlevens N, Fijlstra M, King EE, Stringer AM, van der Velden WJFM, Yazbeck R, Elad S, Bowen JM; for The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO).

Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Peterson, DE, Douglas E. Peterson, Öhrn K, Bowen JM, Fliedner M, Lees J, Loprinzi C, Mori T, Osaguona A, Weikel DS, Elad S, Lalla RV; for the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO).

Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Migliorati, C, Hewson I, Lalla RV, Ian Hewson, Antunes HS, Estilo CL, Hodgson B, Fontana Lopes NN, Schubert MM, Bowen J, Elad S; for the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO).

Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients  - Judith E. Raber-Durlacher, Inger von Bültzingslöwen...et al.

Systematic review of amifostine for the management of oral mucositis in cancer patients. Nicolatou-Galitis, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV; for the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO).


Publications Related to Previous Versions of the Guidelines

Updated clinical practice guidelines for the prevention and treatment of mucositis. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE; for Mucositis Study Section of the Multinational Association of Supportive Care in Cancer(MASCC) and the International Society for Oral Oncology(ISOO). Cancer. 2007 Mar 1;109(5):820-31.

The Mucositis Study Group also published several papers in Supportive Care in Cancer in June 2006. These papers provide detailed information on the evidence underlying the development of the updated guidelines for each category of clinical agent. The link below provides free access to full-text of all of these articles.

The links below provide free full-text access to the papers summarizing the original guidelines, published in 2004.